CA2032748A1 - Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo - Google Patents

Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo

Info

Publication number
CA2032748A1
CA2032748A1 CA002032748A CA2032748A CA2032748A1 CA 2032748 A1 CA2032748 A1 CA 2032748A1 CA 002032748 A CA002032748 A CA 002032748A CA 2032748 A CA2032748 A CA 2032748A CA 2032748 A1 CA2032748 A1 CA 2032748A1
Authority
CA
Canada
Prior art keywords
hiv
vivo
inhibiting
activity
immunodeficiency virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002032748A
Other languages
French (fr)
Other versions
CA2032748C (en
Inventor
Michael H. Davis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002032748A priority Critical patent/CA2032748C/en
Publication of CA2032748A1 publication Critical patent/CA2032748A1/en
Application granted granted Critical
Publication of CA2032748C publication Critical patent/CA2032748C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for inhibiting the activity of human immunodeficiency virus (HIV) in vivo comprises administering to a human host an antimalarial drug, which is capable of exhibiting a protective effect, a curative effect, or of pre-venting transmission of malaria in humans. The antimalarial drug is selected from the group consisting of (a) alkaloids;
(b) 9-amino-acridines;
(c) 4-aminoquinolines;
(d) 8-aminoquinolines;
(e) biguanides;
(f) dihyrofolate reductase inhibitors;
(g) sulfones;
(h) sulfonamides;
(i) mefloquine;
(j) halofantrine;
(k) hydroxyanilino-benzo-naphtyridines; and (l) sesquiterpene lactones.
The antimalarial drug is administered to the human in an amount sufficient to prevent or at least inhibit infection of T
lymphocytes by HIV in vivo or to prevent or at least inhibit replication of HIV in vivo.
CA002032748A 1990-12-19 1990-12-19 Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo Expired - Fee Related CA2032748C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002032748A CA2032748C (en) 1990-12-19 1990-12-19 Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002032748A CA2032748C (en) 1990-12-19 1990-12-19 Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo

Publications (2)

Publication Number Publication Date
CA2032748A1 true CA2032748A1 (en) 1992-06-20
CA2032748C CA2032748C (en) 2003-11-18

Family

ID=4146698

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002032748A Expired - Fee Related CA2032748C (en) 1990-12-19 1990-12-19 Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo

Country Status (1)

Country Link
CA (1) CA2032748C (en)

Also Published As

Publication number Publication date
CA2032748C (en) 2003-11-18

Similar Documents

Publication Publication Date Title
CA2221370A1 (en) Composition for treating condyloma acuminata
CA2067381A1 (en) Treatment of hiv infections and compounds useful therein
CA2229282A1 (en) Use of hyaluronic acid as an immunosuppressant
AU1968992A (en) Preparation of fatty acid medicaments
EP0230574A3 (en) Pharmaceutical compositions against infections caused by lav/htlv iii virus and the use thereof
AU3852989A (en) Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo
CA2179015A1 (en) Use of bis(amidinobenzimidazoles) in the manufacture of medicament for inhibiting retroviral integrase
GR3018879T3 (en) Novel polypeptide and anti-hiv drug prepared therefrom
CA2042972A1 (en) Treatment of ocular hypertension with a synergistic combination for ocular administration
EP0394553A3 (en) Use of fluorine containing pyridone carboxylic acid derivatives for preparing a medicament for the treatment of HIV infections
AU4001289A (en) Heparin fragments and fractions with anti-hiv action
DE3566404D1 (en) Substituted benzopyrans, process for their preparation and their use in medicines
BE1000722A4 (en) PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDES ADAPTED TO GASTROINTESTINAL RESORPTION.
EP0328924A3 (en) Thienotriazolodiazepine compounds and pharmaceutical uses thereof
EP0342587A3 (en) Thienotriazolodiazepine compounds and pharmaceutical uses thereof
EP0297547A3 (en) Use of hydrolyzable tannins for treatement and prophylaxis of aids
WO1990013281A3 (en) Method of suppressing hiv infection
CA2032748A1 (en) Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo
CA2189705A1 (en) Use of flupirtine for the prophylaxis and therapy of diseases associated with an impairment of the haematopoetic cell system
AU7806187A (en) Sulphonamide derivatives for the treatment and prevention of viral diseases
EP0601183A4 (en) Anti-hiv drug.
WO1990005523A3 (en) Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase
CA2093258A1 (en) Cytarabine ocfosfate hard capsule
EP0377823A3 (en) Use of TNF for the preparation of a medicament for the treatment of psoriasis
RU93004785A (en) SOLID CAPSULES OF CITARABIN OXPHOSPHATE

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed